Market revenue in 2023 | USD 104.0 million |
Market revenue in 2030 | USD 164.7 million |
Growth rate | 6.8% (CAGR from 2023 to 2030) |
Largest segment | Outpatient facilities |
Fastest growing segment | Home Care |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Hospitals, Outpatient Facilities, Home Care, Research & Manufacturing |
Key market players worldwide | Thermo Fisher Scientific Inc, Qiagen NV, Illumina Inc, Roche Holding AG ADR, BD, Agilent Technologies Inc, Myriad Genetics Inc, Koninklijke Philips NV, Abbott Laboratories, Hitachi Ltd, Danaher Corp, Prestige Medical |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pancreatic cancer diagnostic market will help companies and investors design strategic landscapes.
Outpatient facilities was the largest segment with a revenue share of 62.69% in 2023. Horizon Databook has segmented the South Korea pancreatic cancer diagnostic market based on hospitals, outpatient facilities, home care, research & manufacturing covering the revenue growth of each sub-segment from 2018 to 2030.
The prevalence of pancreatic cancer has been rising in South Korea, increasing the need for effective diagnostic methods. For instance, new pancreatic cancer cases in the country were estimated to be 9,718 in 2023. Moreover, according to a recent study published in the Journal of Korean Medical Science in January 2024, acute pancreatitis increases the risk of pancreatic cancer.
Furthermore, partnerships between local hospitals & research institutions with global companies are fostering innovation and improving access to cutting-edge diagnostic technologies. For instance, collaborations aimed at integrating AI into imaging techniques are becoming more common.
However, continued investment in R&D by both local startups and established companies, an increase in public awareness campaigns about pancreatic cancer symptoms & the importance of early detection, and ongoing improvements in healthcare infrastructure that facilitate better access to advanced diagnostic services are some of the factors propelling market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea pancreatic cancer diagnostic market , including forecasts for subscribers. This country databook contains high-level insights into South Korea pancreatic cancer diagnostic market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account